 |
Ricin (blocked) conjugated murine mca (anti-b4) |
|---|---|
| Trade Name | |
| Orphan Indication | Acute lymphoblastic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1991-01-24 00:00:00 |
| Sponsor | ImmunoGen, Inc.;830 Winter Street;Waltham, Massachusetts, 02451 |
Related Access Program
Novartis Pharmaceuticals – Acute Lymphoblastic Leukemia
University of California, San Francisco – Acute Lymphoblastic Leukemia
ERYtech Pharma – Acute Lymphoblastic Leukemia
University of California, San Francisco – Acute lymphoblastic leukemia
ERYtech Pharma – Acute lymphoblastic leukemia
Amgen – Acute lymphoblastic leukemia